Free Trial
OTCMKTS:CHHE

China Health Industries (CHHE) Stock Price, News & Analysis

China Health Industries logo
$0.28 0.00 (0.00%)
(As of 12/20/2024 ET)

About China Health Industries Stock (OTCMKTS:CHHE)

Key Stats

Today's Range
$0.28
$0.28
50-Day Range
$0.28
$0.37
52-Week Range
$0.17
$2.96
Volume
N/A
Average Volume
3,876 shs
Market Capitalization
$17.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.

China Health Industries Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
6th Percentile Overall Score

CHHE MarketRank™: 

China Health Industries scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for China Health Industries.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of China Health Industries is -13.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of China Health Industries is -13.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    China Health Industries has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of China Health Industries have been sold short.
  • Short Interest Ratio / Days to Cover

    China Health Industries has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    China Health Industries does not currently pay a dividend.

  • Dividend Growth

    China Health Industries does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of China Health Industries have been sold short.
  • Short Interest Ratio / Days to Cover

    China Health Industries has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for China Health Industries this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, China Health Industries insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.30% of the stock of China Health Industries is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about China Health Industries' insider trading history.
Receive CHHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Health Industries and its competitors with MarketBeat's FREE daily newsletter.

CHHE Stock News Headlines

China Health Industries Holdings, Inc.
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
See More Headlines

CHHE Stock Analysis - Frequently Asked Questions

China Health Industries' stock was trading at $0.4875 at the beginning of 2024. Since then, CHHE shares have decreased by 43.6% and is now trading at $0.2750.
View the best growth stocks for 2024 here
.

Shares of CHHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that China Health Industries investors own include NVIDIA (NVDA), Labor Smart (LTNC), Acrivon Therapeutics (ACRV), Chevron (CVX), M&T Bank (MTB), NIO (NIO) and Processa Pharmaceuticals (PCSA).

Company Calendar

Today
12/22/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CHHE
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-410,000.00
Pretax Margin
-1,419.90%

Debt

Sales & Book Value

Annual Sales
$110,000.00
Cash Flow
$0.00 per share
Book Value
$0.60 per share

Miscellaneous

Free Float
44,618,000
Market Cap
$17.86 million
Optionable
Not Optionable
Beta
-20.44
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CHHE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners